This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Samuel J. Klempner ...

This discussion provides a forward-looking discussion on how the role of PD-1 inhibitors may continue to evolve in the ...

Perioperative chemotherapy as well as neoadjuvant chemoradiation therapy followed by surgery (trimodality therapy) are associated with improved overall survival in patients with locally advanced ...

Improving evidence-based treatment selection and patient-centered care in upper GI cancers: A Project ECHO initiative. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

This discussion looks ahead at how the role of PD-1 inhibitors may continue to evolve in the treatment of esophageal squamous ...

Trends in gastric cancer mortality in the US: A population-based analysis, 1999-2023. National trends in mortality of gastric cancer among older adults (70+) from 1990 to 2021 across 204 nations: A ...

SAN MATEO, Calif.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S.

(a) Diagnosed with achalasia; (b) Underwent peroral endoscopic myotomy (POEM) surgery for achalasia; (c) Severe reflux symptoms 23 months later; (d) Esophageal squamous cell carcinoma located 25 cm ...

SAN MATEO, Calif.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines, today announced that the ...